Literature DB >> 8713111

Ligand-induced dimerization of the extracellular domain of the TGF-beta receptor type II.

O Letourneur1, J F Goetschy, M Horisberger, M G Grütter.   

Abstract

Transforming growth factor-beta (TGF-beta) signals by mediating the association of two distinct transmembrane serine/threonine kinase receptors, the type I (T beta RI) and II (T beta RII). Here, we took advantage of recombinant human T beta RII extracellular domain (T beta RII-ED) to analyze TGF-beta/T beta RII complex formation which is the initial event in the construction of a signaling complex. We found that recombinant T beta RII-ED binds TGF-beta 3 more efficiently than TGF-beta 2 and therefore maintains the native T beta RII binding selectivity for the different TGF-beta isoforms. Biochemical analysis showed that free T beta RII-ED is expressed as a monomer. Upon ligand binding, both TGF-beta 3 and -beta 2 isoforms induce homodimerization of T beta RII-ED, each TGF-beta subunit being able to bind one T beta RII-ED molecule. These results suggested that ligand dependent receptor dimerization may be an important early step in the TGF-beta signaling complex formation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8713111     DOI: 10.1006/bbrc.1996.1088

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Different domains regulate homomeric and heteromeric complex formation among type I and type II transforming growth factor-beta receptors.

Authors:  Maya Mouler Rechtman; Alex Nakaryakov; Keren E Shapira; Marcelo Ehrlich; Yoav I Henis
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

2.  Single-molecule imaging reveals transforming growth factor-beta-induced type II receptor dimerization.

Authors:  Wei Zhang; Yaxin Jiang; Qiang Wang; Xinyong Ma; Zeyu Xiao; Wei Zuo; Xiaohong Fang; Ye-Guang Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-31       Impact factor: 11.205

3.  Paracrine co-delivery of TGF-β and IL-2 using CD4-targeted nanoparticles for induction and maintenance of regulatory T cells.

Authors:  Michael D McHugh; Jason Park; Ross Uhrich; Wenda Gao; David A Horwitz; Tarek M Fahmy
Journal:  Biomaterials       Date:  2015-05-15       Impact factor: 15.304

4.  Oligomeric structure of type I and type II transforming growth factor beta receptors: homodimers form in the ER and persist at the plasma membrane.

Authors:  L Gilboa; R G Wells; H F Lodish; Y I Henis
Journal:  J Cell Biol       Date:  1998-02-23       Impact factor: 10.539

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.